Celecoxib Japan Observational Study for the Patients With Acute Pain
Celecoxib Japan Observational Study for the Patients With Acute Pain
This study is to assess the safety and efficacy of celecoxib on the pain relief from acute
 pain.
Patients with traumatic pain, post-surgical and tooth extract pain will be included in this
 study. Patients will receive Celecoxib for 2 weeks and the efficacy on pain relief and the
 safety will be evaluated.
Inclusion Criteria:

 -  Patients with traumatic pain, post-surgical pain and tooth extract pain

 Exclusion Criteria:

 -  Hyperreactive to sulfonamide

 -  Aspirin asthma patients

 -  Peptidic ulcer patients

 -  Serious liver disease patients

 -  Serious kidney disease patients

 -  Serious heart failure patients

 -  End of pregnancy